POET Earnings Preview

POET has executed meaningfully on its product roadmap—the Lite-On partnership, OFC technology demonstrations, and Marvell validation are legitimate proof of commercial progress. However, the stock has rallied 12% in the month leading into earnings and now sits only 33% below its 52-week high despite deeply unprofitable fundamentals (-$0.06 EPS consensus, $1M revenue), a consistent pattern of missing estimates, and decelerating revenue momentum. The critical vulnerability is that OFC, the primary near-term catalyst, concluded March 19—twelve days before the March 31 earnings announcement—exhausting investor enthusiasm well before results. The market will confront the reality that product demos do not translate to Q1 profitability: consensus expectations remain deeply negative, and the company's historical miss pattern suggests disappointment is likely. Post-conference momentum will fade as investors reset expectations for an early-stage inflection story and realize the valuation disconnect between hype and current earnings reality, triggering a downside reaction on or shortly after the announcement.